sell all AFFY all in SVNT you will get back everything
Sobi and Savient Pharmaceuticals Inc Announce Co-Promotion Agreement for Kineret in US
Tuesday, 19 Feb 2013 08:30am EST
Sobi and Savient Pharmaceuticals Inc announced that they have entered into an agreement for the co-promotion of Kineret (anakinra) in the U.S. Kineret, a recombinant IL-1 receptor antagonist, is a treatment for rheumatoid arthritis (RA) and indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active RA in patients 18 years of age or older who have failed one or more disease modifying antirheumatic drugs (DMARDs). Kineret is also indicated in the U.S. for the treatment of children and adults with the severe form of Cryopyrin-Associated Periodic Syndromes (CAPS) called Neonatal-Onset Multisystem Inflammatory Disease (NOMID). Under the terms of the agreement, Sobi has granted to Savient the exclusive right to co-promote the sale of Kineret with Sobi in the U.S. Savient will market and promote Kineret beginning April 1, 2013. Sobi will remain responsible for all Kineret commercial drug manufacturing, supply, safety, and regulatory activities. About Swedish Orphan Biovitrum AB (Sobi) Sobi is an international specialty healthcare company dedicated to rare diseases.
Latest Developments for Savient Pharmaceuticals IncSavient Pharmaceuticals Inc Announces CEO Appointment
Savient Pharmaceuticals Inc Announces That New Analysis of Phase III Trials Shows Gout Patients with Chronic Kidney Disease at Any Stage Responded to KRYSTEXXA
Savient Pharmaceuticals Inc Appoints David Y. Norton Interim Chief Executive Officer
Latest Key Developments in BiotechnologyDynavax Technologies Corp Announces Management Changes
Intercept Pharmaceuticals Inc Announces Additional Results Of Global Primary Biliary Cirrhosis Study Group Analysis
Hhahaha, you are the only one who owns SVNT stock and you expect me to sell my shares and buy svnt... what kinda of #$%$ are you smoking because i would like to have some of that... sorry but you arent going to have my AFFY shares...